Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Smoke Away Endorsements Up In Smoke, Endorsers Singed In FTC Suit

This article was originally published in The Tan Sheet

Executive Summary

FTC included two healthcare professionals who provided product endorsements in a recently settled false advertising suit against marketers of the Smoke Away "natural" smoking cessation system

You may also be interested in...



Flu Vaccine “Alternative” Claims For Supplements Targeted By FTC

The Federal Trade Commission is closely scrutinizing the marketing of dietary supplement products for flu treatment and prevention during the current shortage of the influenza vaccine in the U.S

Enforma Spokesman Garvey Not Liable For Weight-Loss Claims – Judge

The Federal Trade Commission presented insufficient evidence to support its claim that a former baseball player's statements about the efficacy of Enforma Natural Products' weight-loss supplements were "knowingly false" or made with "reckless disregard of the truth," a federal judge has concluded

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098590

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel